Antonella Mencacci Selected Research

Antonella Mencacci Research Topics

Disease

13	Infections 09/2021 - 01/2013
13	Sepsis (Septicemia) 09/2021 - 12/2011
5	Bacteremia 04/2021 - 01/2012
4	COVID-19 09/2021 - 07/2020
3	Inflammation (Inflammations) 01/2018 - 11/2014
3	Candidiasis (Moniliasis) 01/2018 - 01/2013
2	Cross Infection (Nosocomial Infection) 12/2021 - 08/2011
2	Bacterial Infections (Bacterial Infection) 05/2020 - 12/2011
2	Gonorrhea 06/2018 - 10/2014
2	Vulvovaginal Candidiasis 01/2018 - 12/2017
2	Nocardia Infections 06/2016 - 01/2013
1	Viremia 02/2021
1	Pyoderma 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Measles 08/2020
1	Thrombosis (Thrombus) 07/2020
1	Central Nervous System Infections (Central Nervous System Infection) 06/2016
1	Pneumonia (Pneumonitis) 06/2016
1	Aspiration Pneumonia 01/2015
1	Meningitis 01/2015
1	Urinary Tract Infections (Urinary Tract Infection) 01/2015
1	Disease Progression 01/2015
1	Reinfection 06/2014
1	Surgical Wound Infection 06/2014
1	Wounds and Injuries (Trauma) 06/2014
1	Fever (Fevers) 05/2014
1	Neoplasms (Cancer) 01/2013
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2013
1	Hematologic Neoplasms (Hematological Malignancy) 01/2013
1	Legionellosis 08/2011
1	Suppuration 11/2009
1	Mastitis 11/2009
1	Respiratory Insufficiency (Respiratory Failure) 04/2008
1	Aspergillosis 05/2002
1	Invasive Pulmonary Aspergillosis 05/2002
1	Mycoses (Diseases, Fungus) 05/2002

Drug/Important Bio-Agent (IBA)

5	ProcalcitoninIBA 08/2016 - 01/2012
4	Anti-Bacterial Agents (Antibiotics)IBA 06/2018 - 11/2009
3	Pharmaceutical PreparationsIBA 12/2021 - 01/2015
3	AntigensIBA 09/2021 - 08/2011
2	Viral RNAIBA 09/2021 - 02/2021
2	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 01/2021 - 06/2016
2	Amoxicillin (Wymox)FDA LinkGeneric 01/2021 - 06/2016
2	Meropenem (Merrem)FDA LinkGeneric 12/2020 - 01/2015
2	Immunoglobulin G (IgG)IBA 08/2020 - 07/2020
2	AntibodiesIBA 07/2020 - 05/2002
2	C-Reactive ProteinIBA 08/2016 - 11/2014
2	DNA (Deoxyribonucleic Acid)IBA 06/2016 - 11/2013
2	Interleukin-22 (IL-22)IBA 08/2015 - 01/2013
2	Colistin (Coly-Mycin)FDA Link 01/2015 - 06/2014
1	Carbapenems (Carbapenem Antibiotics)IBA 08/2021
1	Linezolid (Zyvox)FDA Link 04/2021
1	insulin receptor-related receptor (IRR)IBA 04/2021
1	RNA (Ribonucleic Acid)IBA 02/2021
1	Glutathione (Reduced Glutathione)IBA 01/2021
1	Mupirocin (Bactroban)FDA LinkGeneric 01/2021
1	Cephalothin (Cefalotin)FDA Link 01/2021
1	Clindamycin (Cleocin)FDA LinkGeneric 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Doxycycline (Periostat)FDA LinkGeneric 01/2021
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2021
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2021
1	EnrofloxacinIBA 01/2021
1	Oxacillin (Prostaphlin)FDA LinkGeneric 01/2021
1	ceftazidime drug combination avibactamIBA 12/2020
1	Immunoglobulin M (IgM)IBA 07/2020
1	Antiphospholipid AntibodiesIBA 07/2020
1	Immunoglobulin A (IgA)IBA 07/2020
1	LigandsIBA 01/2018
1	ChemokinesIBA 01/2018
1	CytokinesIBA 01/2018
1	EpitopesIBA 01/2018
1	Virulence Factors (Pathogenicity Factors)IBA 12/2017
1	Levofloxacin (Levaquin)FDA Link 06/2016
1	Formaldehyde (Formol)FDA Link 06/2016
1	ParaffinIBA 06/2016
1	InflammasomesIBA 08/2015
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 08/2015
1	methanesulfonic acid (methanesulfonate)IBA 01/2015
1	TeicoplaninIBA 01/2015
1	Anti-Infective Agents (Microbicides)IBA 10/2014
1	Daptomycin FDA Link 06/2014
1	Ciprofloxacin (Cipro)FDA LinkGeneric 06/2014
1	Ceftazidime (Fortum)FDA LinkGeneric 06/2014
1	Serum AlbuminIBA 05/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2013
1	AcidsIBA 01/2013
1	Yeast Killer FactorsIBA 05/2002
1	Monoclonal AntibodiesIBA 05/2002

Therapy/Procedure

9	Therapeutics 09/2021 - 12/2011
1	Replantation 06/2014
1	Prostheses and Implants (Prosthesis) 06/2014
1	Hip Prosthesis 06/2014
1	Debridement 06/2014
1	Lasers (Laser) 01/2013
1	Laparotomy 04/2008
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 05/2002